Edition:
United Kingdom

Panacea Biotec Ltd (PNCA.NS)

PNCA.NS on National Stock Exchange of India

159.00INR
10:28am GMT
Change (% chg)

Rs-4.70 (-2.87%)
Prev Close
Rs163.70
Open
Rs164.50
Day's High
Rs168.00
Day's Low
Rs156.45
Volume
28,304
Avg. Vol
54,295
52-wk High
Rs364.35
52-wk Low
Rs140.95

Latest Key Developments (Source: Significant Developments)

Panacea Biotec Gets Shareholders' Nod For Reappointment Of Rajesh Jain As MD
Monday, 1 Oct 2018 

Oct 1 (Reuters) - Panacea Biotec Ltd ::GETS SHAREHOLDERS' NOD FOR REAPPOINTMENT OF SOSHIL KUMAR JAIN AS WHOLE-TIME DIRECTOR DESGINATED AS CHAIRMAN.GETS SHAREHOLDERS' NOD FOR REAPPOINTMENT OF RAJESH JAIN AS MD.GETS SHAREHOLDERS' NOD FOR RE-APPOINTMENT OF SANDEEP JAIN AS JOINT MD.  Full Article

Panacea Biotec Enters Into Agreement With Natco Pharma And Breckenridge Pharma
Monday, 27 Aug 2018 

Aug 27 (Reuters) - Panacea Biotec Ltd ::SAYS ENTERED INTO TRIPARTITE AGREEMENT WITH NATCO PHARMA AND BRECKENRIDGE PHARMACEUTICAL.AGREEMENT FOR THE MANUFACTURE AND SUPPLY OF AZACITIDINE INJECTION FOR THE U.S. MARKET.  Full Article

India's Panacea Biotec June-Qtr Net Loss Narrows
Tuesday, 14 Aug 2018 

Aug 14 (Reuters) - Panacea Biotec Ltd ::JUNE QUARTER NET LOSS 368.3 MILLION RUPEES VERSUS LOSS OF 479.9 MILLION RUPEES YEAR AGO.JUNE QUARTER REVENUE FROM OPERATIONS 951.1 MILLION RUPEES VERSUS 1.08 BILLION RUPEES YEAR AGO.  Full Article

Panacea Biotec Approves Elevation Of Rajesh Jain To Position Of MD
Monday, 12 Mar 2018 

March 12 (Reuters) - Panacea Biotec Ltd ::SAYS CO APPROVED ELEVATION OF RAJESH JAIN, JOINT MD TO POSITION OF MD OF CO.  Full Article

Panacea Biotec Says U.S. FDA Accepts Co's Marketing Application For Generic Cancer Drug
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - Panacea Biotec Ltd ::SAYS U.S. FDA ACCEPTS CO'S ANDA FOR PACLITAXEL PROTEIN BOUND PARTICLES.  Full Article

India's Panacea Biotec Sept-qtr loss widens
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - Panacea Biotec Ltd :Sept quarter net loss 56.3 million rupees versus loss 49.5 million rupees year ago.Sept quarter total income from operations 1.54 billion rupees versus 1.62 billion rupees year ago.  Full Article

India's Panacea Biotec Sept-qtr loss widens
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Panacea Biotec Ltd :Sept quarter net loss 56.3 million rupees versus loss 49.5 million rupees year ago.Sept quarter revenue from operations 1.53 billion rupees versus 1.41 billion rupees year ago.  Full Article

Panacea Biotec says ANDA of Prasugrel approved by U.S. FDA​
Tuesday, 24 Oct 2017 

Oct 24 (Reuters) - Panacea Biotec Ltd :First-to-file ANDA of Prasugrel 5mg & 10mg tablets approved by U.S. FDA​.  Full Article

Panacea Biotec gets GMP compliance certificate from state service of Ukraine on Medicines and Drug Control‍​
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Panacea Biotec Ltd :Panacea Biotec - gets certificate of GMP compliance from state service of Ukraine on Medicines and Drug Control‍​.Panacea Biotec - certificate for manufacturing authorization for 22 medicinal products.  Full Article

Panacea Biotec expands collaboration with Apotex to launch prasugrel in US
Monday, 11 Sep 2017 

Sept 11 (Reuters) - Panacea Biotec Ltd :Says expands collaboration with Apotex to launch prasugrel in US.Says Apotex shall be responsible for sales, distribution of product in USA, co to be responsible for manufacturing, supply.  Full Article

No consensus analysis data available.